NCT00056238View on ClinicalTrials.gov

Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2003

Conditions
StrokeNeurologic Diseases, General
Interventions
DRUG

NC-758 (Anti amyloidotic [Aß] agent)

Trial Locations (5)

10032

Columbia University, New York

19107

Thomas Jefferson University, Philadelphia

40506

University of Kentucky, Lexington

45267

University of Cincinnati, Cincinnati

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Bellus Health Inc. - a GSK company

INDUSTRY

NCT00056238 - Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy | Biotech Hunter | Biotech Hunter